热门资讯> 正文
DeliverSpring Health报告第三季度初步收入,提高25财年指导
2025-10-21 04:23
- BrightSpring Health Services, Inc. (NASDAQ:BTSG) on Monday reported preliminary third-quarter 2025 revenue of $3.33 billion, up 28% from $2.60 billion a year earlier.
- Adjusted EBITDA rose 37% to $160 million, while net income was $37.5 million versus a $25.7 million loss in the third quarter 2024.
- The company raised full-year 2025 guidance, projecting revenue of $12.4–12.7 billion, up 23–26%, and adjusted EBITDA of $605–615 million, up 32–34%.
- Revenue growth is driven by the Pharmacy segment ($10.95–11.2 billion) and Provider segment ($1.45–1.5 billion).
- BrightSpring plans to report final third-quarter results on Oct. 28 and host a conference call the same day.
- BTSG -2.19% after hours to $29.8.
- Source: Press Release
More on BrightSpring Health Services
- BrightSpring Health Services, Inc. (BTSG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- BrightSpring Health Services, Inc. (BTSG) Q2 2025 Earnings Call Transcript
- BrightSpring Health Services, Inc. 2025 Q2 - Results - Earnings Call Presentation
- BrightSpring to join S&P SmallCap 600, replacing Veritex
- BrightSpring raises 2025 adjusted EBITDA guidance to $605M while expanding specialty pharmacy and infusion growth
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。